메뉴 건너뛰기




Volumn 16, Issue 11, 2014, Pages 1249-1255

Effect of extended follow-up in a specialized heart failure clinic on adherence to guideline recommended therapy: NorthStar Adherence Study

Author keywords

Adherence; Angiotensin converting enzyme inhibitor; Beta blocker; Heart failure clinic; Mineralocorticoid receptor antagonist; Systolic heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID ANTAGONIST;

EID: 84916604034     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.176     Document Type: Article
Times cited : (23)

References (21)
  • 1
    • 4143055922 scopus 로고    scopus 로고
    • Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials
    • McAlister FA, Stewart S, Ferrua S, McMurray JJ,. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-819.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 810-819
    • McAlister, F.A.1    Stewart, S.2    Ferrua, S.3    McMurray, J.J.4
  • 2
    • 67650535210 scopus 로고    scopus 로고
    • What is the strength of evidence for heart failure disease-management programs?
    • Clark AM, Savard LA, Thompson DR,. What is the strength of evidence for heart failure disease-management programs? J Am Coll Cardiol 2009; 54: 397-401.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 397-401
    • Clark, A.M.1    Savard, L.A.2    Thompson, D.R.3
  • 4
    • 39549118139 scopus 로고    scopus 로고
    • Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)
    • Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Investigators
    • Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, van Gilst WH, Lok DJ, Dunselman PH, Tijssen JG, Hillege HL, van Veldhuisen DJ, Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Investigators. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 2008; 168: 316-324.
    • (2008) Arch Intern Med , vol.168 , pp. 316-324
    • Jaarsma, T.1    Van Der Wal, M.H.2    Lesman-Leegte, I.3    Luttik, M.L.4    Hogenhuis, J.5    Veeger, N.J.6    Sanderman, R.7    Hoes, A.W.8    Van Gilst, W.H.9    Lok, D.J.10    Dunselman, P.H.11    Tijssen, J.G.12    Hillege, H.L.13    Van Veldhuisen, D.J.14
  • 6
    • 84871085465 scopus 로고    scopus 로고
    • Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: A nested case-control analysis of IMPROVE HF
    • Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW,. Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of IMPROVE HF. J Am Heart Assoc 2012; 1: 16-26.
    • (2012) J Am Heart Assoc , vol.1 , pp. 16-26
    • Fonarow, G.C.1    Albert, N.M.2    Curtis, A.B.3    Gheorghiade, M.4    Liu, Y.5    Mehra, M.R.6    O'Connor, C.M.7    Reynolds, D.8    Walsh, M.N.9    Yancy, C.W.10
  • 11
    • 84856708566 scopus 로고    scopus 로고
    • Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction
    • Heart Failure Optimal Outcomes from Pharmacy Study (HOOPS) Investigators
    • Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, Rae B, McMurray JJ, Heart Failure Optimal Outcomes from Pharmacy Study (HOOPS) Investigators. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J 2012; 33: 314-324.
    • (2012) Eur Heart J , vol.33 , pp. 314-324
    • Lowrie, R.1    Mair, F.S.2    Greenlaw, N.3    Forsyth, P.4    Jhund, P.S.5    McConnachie, A.6    Rae, B.7    McMurray, J.J.8
  • 13
    • 84879497662 scopus 로고    scopus 로고
    • Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: A multicentre randomized clinical trial (NorthStar monitoring study)
    • NorthStar Investigators
    • Schou M, Gustafsson F, Videbaek L, Andersen H, Toft J, Nyvad O, Ryde H, Fog L, Jensen JC, Nielsen OW, Lind-Rasmussen S, Abdulla J, Hildebrandt PR, NorthStar Investigators. Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study). Eur J Heart Fail 2013; 15: 818-827.
    • (2013) Eur J Heart Fail , vol.15 , pp. 818-827
    • Schou, M.1    Gustafsson, F.2    Videbaek, L.3    Andersen, H.4    Toft, J.5    Nyvad, O.6    Ryde, H.7    Fog, L.8    Jensen, J.C.9    Nielsen, O.W.10    Lind-Rasmussen, S.11    Abdulla, J.12    Hildebrandt, P.R.13
  • 16
    • 84882415231 scopus 로고    scopus 로고
    • Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: A randomized, double-blind trial
    • Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, Nowack C, Kolkhof P, Kim SY, Zannad F,. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J 2013; 34: 2453-2463.
    • (2013) Eur Heart J , vol.34 , pp. 2453-2463
    • Pitt, B.1    Kober, L.2    Ponikowski, P.3    Gheorghiade, M.4    Filippatos, G.5    Krum, H.6    Nowack, C.7    Kolkhof, P.8    Kim, S.Y.9    Zannad, F.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.